Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04988438

Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19

Gastrointestinal Motility Disorder Clinical Trial

Official title:
Gastrointestinal Motor Disorders (Esophageal and Anorectal) in Patients After COVID-19 Infection

Clinical Trial Summary

The patients who had COVID-19 infection, and after that reported for one of the signs of gastrointestinal disorder (esophageal and anorectal) will be underwent to esophageal and anorectal motor monitoring investigation (HRM manometry) on standard protocol.

Clinical Trial Description

The patients who had COVID-19 infection, and after that reported for one of the signs of gastrointestinal (esophageal and anorectal disorder) will be underwent to esophageal and anorectal motor monitoring investigation (HRM manometry) on standard protocol. The patients with dysphagia, chest discomfort during swallowing, or chest pain during swallowing, patients with obstipation, fecal evacuation symptoms, lower stomach discomfort before defecation etc. will be included in the study. In all of them other gastrointestinal diseases will be excluded by standard routine laboratory investigation, ultrasound, routine endoscopy investigation and 24 hours impedance pH-measurement. After manometric measurement of esophagus and anorectal region to standard protocol by using MMS-HRM 360 monitoring system with 36 canals catheter for esophagus and 24 canals catheter for anorectal monitoring, data will be calculated by using statistics. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04988438
Study type Observational
Source University Hospital Dubrava
Contact Žarko Babic, prof.dr.sc.
Phone +38512903390
Email zarko.babic@zg.t-com.hr
Status Recruiting
Phase
Start date August 15, 2021
Completion date August 31, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT04429802 - The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity N/A
Completed NCT01644240 - A Phase 1, Multiple Intravenous Dose Study to Examine the Safety, Tolerability, and Pharmacokinetics of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects Phase 1
Withdrawn NCT04244877 - Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Phase 3
Terminated NCT02573519 - Gastrointestinal Motility Among Diabetes Patients N/A
Recruiting NCT04764019 - Intestinal Dysmotility in Patients With Functional Digestive Symptoms N/A
Completed NCT03012594 - Lanreotide in the Treatment of Small Bowel Motility Disorders Phase 2
Not yet recruiting NCT05268328 - The Effect of Foot Reflexology After Cesarean Section
Completed NCT02245165 - Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades Phase 1
Completed NCT03552510 - Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility N/A
Completed NCT01394055 - Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis Phase 1
Not yet recruiting NCT05989763 - Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis N/A
Active, not recruiting NCT00793195 - Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants? Phase 2
Recruiting NCT04208828 - IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
Recruiting NCT06347367 - Short-term Effect of Exercise and Self-manual Approaches to Bloating - Distention N/A
Completed NCT01635608 - Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water Phase 1